Meriam Kabbaj
Chief Tech/Sci/R&D Officer at GENFIT
Meriam Kabbaj active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENFIT | Chief Tech/Sci/R&D Officer | 30/11/2022 | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Director/Board Member | 31/12/2014 | - |
| Chief Operating Officer | 31/12/2014 | - | |
| Founder | 31/12/2014 | - |
Career history of Meriam Kabbaj
Training of Meriam Kabbaj
| University of Montréal | Doctorate Degree |
Statistics
International
| Canada | 2 |
| Switzerland | 2 |
| France | 2 |
Operational
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GENFIT | Health Technology |
| Private companies | 1 |
|---|---|
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Meriam Kabbaj
- Experience
